Brief: Hansa Biopharma Announces Successful Execution Of A Directed Share Issue Of SEK 416 Million (~USD 40 Million)

Hansa Biopharma AB

13/12/2022 24:03

Dec 12 (Reuters) - Hansa Biopharma AB  HNSA.ST :
    * HANSA BIOPHARMA ANNOUNCES SUCCESSFUL EXECUTION OF A
DIRECTED
SHARE ISSUE OF SEK 416 MILLION (~USD 40 MILLION)
    * ANNOUNCES THAT BOARD OF DIRECTORS HAS RESOLVED TO ISSUE
7.8
MILLION NEW ORDINARY SHARES IN A DIRECTED SHARE ISSUE
    * PRICE FOR NEW SHARES IS SEK 53.00 PER NEW SHARE

Source text for Eikon:  ID:nWkr4vKkfb 
Further company coverage:  HNSA.ST 
 ((Reuters.Briefs@thomsonreuters.com;))